Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 16/2023

Inhalt (61 Artikel)

Research

Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients

Maomei Ruan, Cheng Chang, Jianwen Sun, Liu Liu, Lihua Wang, Bei Lei, Hui Yan, He Zhang, Wenhui Xie, Yuetao Wang

Research

Predictive value of 18F-FDG PET/CT multi-metabolic parameters and tumor metabolic heterogeneity in the prognosis of gastric cancer

Jianlin Wang, Xiaopeng Yu, Aiqi Shi, Long Xie, Liqun Huang, Yingrui Su, Jinshun Zha, Jiangyan Liu

Research

A cohort study investigating the role of Bisphenol A in the molecular pathogenesis of breast cancer

Ayesha Ishtiaq, Maryam Anyat Nasrullah, Jahangir Sarwar Khan, Sara Malik, Usman Tareen, Mariam Anees, Aneesa Sultan, Iram Murtaza

Research

PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target

Naoya Iwamoto, Hideya Onishi, Shogo Masuda, Akira Imaizumi, Keita Sakanashi, Shinji Morisaki, Shinjiro Nagao, Satoko Koga, Keigo Ozono, Masayo Umebayashi, Takashi Morisaki, Masafumi Nakamura

Research

A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma

Kai Lei, Zhuofan Deng, Jiaguo Wang, Hongxiang Wang, Run Hu, Yin Li, Xingxing Wang, Jie Xu, Ke You, Zuojin Liu

Open Access Research

The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer

Wen-jing Yun, Jun Li, Nan-chang Yin, Cong-yu Zhang, Zheng-guo Cui, Li Zhang, Hua-chuan Zheng

Research

miR-9-5p expression is associated with vascular invasion and prognosis in hepatocellular carcinoma, and in vitro verification

Yuan Chen, Hao Xu, Hao Tang, Hongyuan Li, Chi Zhang, Shengjie Jin, Dousheng Bai

Open Access Research

In vitro antineoplastic effects of MK0752 in HPV-positive head and neck squamous cell carcinoma

Sara Varatanovic, Stefan Stoiber, Markus Haas, Alexander Lein, Lorenz Kadletz-Wanke, Faris F. Brkic

Open Access Research

The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma

Shengyue Chen, Xukai Luo, Baicai Yang, Jingming Zhuang, Jinshuai Guo, Yingjie Zhu, Jiahang Mo

Open Access Research

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer

Eline S. Zwart, Thomas van Ee, Deesje Doppenberg, Arantza Farina, Johanna W. Wilmink, Eva Versteijne, Olivier R. Busch, Marc G. Besselink, Laura L. Meijer, Yvette van Kooyk, Reina E. Mebius, Geert Kazemier

Research

Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study

Yangxun Pan, Ze Yuan, Jiongliang Wang, Siegmund Ngai, Zhiwen Hu, Liyang Sun, Zhenyun Yang, Dandan Hu, Minshan Chen, Zhongguo Zhou, Yaojun Zhang

Open Access Research

Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis

Friederike Braulke, Kathrin Kober, Stefan Rieken, Tonia Brand, Tobias Hartz, Stefanie Seipke, Thomas Asendorf, Jörg Haier

Open Access Research

Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up

Ramona Stelmach, Leonidas Apostolidis, Steffen Kahle, Leila Sisic, Henrik Nienhüser, Tim Frederik Weber, Dirk Jäger, Georg Martin Haag

Research

Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules

Zhanrong Feng, Qian Zhao, Ying Ding, Yue Xu, Xiaoxiao Sun, Qiang Chen, Yang Zhang, Juan Miao, Jingjing Zhu

Research

Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

Izzet Dogan, Esra Aydin, Nijat Khanmammadov, Nail Paksoy, Ferhat Ferhatoğlu, Naziye Ak, Selman Emiroglu, Kamuran Ibis, Semen Onder, Mustafa Tukenmez, Neslihan Cabioglu, Seden Kucucuk, Mahmut Muslumanoğlu, Vahit Ozmen, Pinar Saip, Abdullah Igci, Adnan Aydiner

Research

Survival impact of bowel resection in patients with FIGO stage II–IV ovarian cancer

Qing-miao Wang, Yao Xiao, Yue-xi Liu, Xing Wei, Qiu-ying Gu, Hua Linghu, Bing Liu

Open Access Research

Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study

Thu Thi Pham, Katharina Nimptsch, Nikos Papadimitriou, Krasimira Aleksandrova, Mazda Jenab, Marc J. Gunter, Loic Le Marchand, Li Li, Brigid M. Lynch, Sergi Castellví-Bel, Amanda I. Phipps, Stephanie L. Schmit, Hermann Brenner, Shuji Ogino, Edward Giovannucci, Tobias Pischon

Research

Development and validation of a contrast-enhanced CT-based radiomics nomogram for differentiating mass-like thymic hyperplasia and low-risk thymoma

Wentao Dong, Situ Xiong, Xiaolian Wang, Shaobo Hu, Yangchun Liu, Hao Liu, Xin Wang, Jiaqi Chen, Yingying Qiu, Bing Fan

Research

HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma

Sumei Xu, Haiyan Xiao, Tao Song, Youjie Zeng, Chenglong Wei, Tiange Chen, Zhongxu Hu, Ren Guo, Dai Li, Minghao Jiang

Research

A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression

Yingyi Feng, Yongshun Dong, Boqi Rao, Yonghui Yu, Wenpeng Su, Jie Zeng, Eryong Zhao, Yongxiu Chen, Shenying Fang, Yifeng Zhou, Jiachun Lu, Fuman Qiu

Open Access Research

Detection of metastases using circulating tumour DNA in uveal melanoma

Aaron B. Beasley, Daniël P. de Bruyn, Leslie Calapre, Zeyad Al-Ogaili, Timothy W. Isaacs, Jacqueline Bentel, Anna L. Reid, Roy S. Dwarkasing, Michelle R. Pereira, Muhammad A. Khattak, Tarek M. Meniawy, Michael Millward, Erwin Brosens, Annelies de Klein, Fred K. Chen, Emine Kiliҫ, Elin S. Gray

Research

Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia

Huawei Zhu, Yanbo Xu, Jun Xia, Xu Guo, Yujie Fang, Jingzhi Fan, Fangjun Li, Jinhong Wu, Guoliang Zheng, Yubo Liu

Research

Impact of early vs late palliative care referrals on healthcare utilization in patients with pancreatic cancer

Roberto Gonzalez, Shruthi Srinivas, Brittany L. Waterman, Mehak Chawla, Jordan M. Cloyd, Gennaro Di Tosto, Timothy M. Pawlik, Angela Sarna, Laura J. Rush, Ann Scheck McAlearney, Aslam Ejaz

Open Access Research

Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets

Jie Xiao, Fengli Huang, Lin Li, Lianru Zhang, Li Xie, Baorui Liu

Research

Survival nomograms for patients with retroperitoneal soft tissue sarcoma based on the SEER database and an external cohort

Jing Wu, Yunfei Zhang, Gang Yao, Abudusalamu Tuersunmaimaiti, Yilizhati Azhati, Alimujiang Mamuti, Hao Wen, Tuerhongjiang Tuxun

Research

Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer

Yuankui Zhu, Dianbao Zuo, Ke Wang, Sina Lan, Huixia He, Liu Chen, Xin Chen, Mingqian Feng

Open Access Research

Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis

Ying Xiong, Feifei Gu, Jin Cui, Yuting Liu, Min Sun, Xinyue Gu, Luhui Zhong, Kai Zhang, Li Liu

Research

Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin’s suppression of oral cancer

Hui Dong, Mengli Li, Hong Chen, Linqing Tian, Wei Wei, Shibing Wang, Gang Cheng, Shuyan Liu

Research

Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response

Yue Jiang, Yingquan Ye, Yi Huang, Yue Wu, Gaoxiang Wang, Zhongxuan Gui, Mengmeng Zhang, Mei Zhang

Research

Results of fusion prostate biopsy comparing with cognitive and systematic biopsy

Marta Guerra-Lacambra, Yaiza Yañez-Castillo, Mar Folgueral-Corral, María Teresa Melgarejo-Segura, María del Carmen Cano-García, Francisco Javier Sánchez-Tamayo, José Luis Martín-Rodríguez, Miguel Angel Arrabal-Polo, Miguel Arrabal-Martin

Research

Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report

Hajime Sasagawa, Kazuyuki Numakura, Mizuki Mori, Mizuki Kobayashi, Soki Kashima, Ryohei Yamamoto, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Hiroshi Nanjo, Tomonori Habuchi

Research

Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer

Hélène Doubre, Laurent Greillier, Grégoire Justeau, Charles Ricordel, Aurélie Swalduz, Hubert Curcio, Olivier Bylicki, Jean-Bernard Auliac, Florian Guisier, Laurence Bigay-Game, Marie Bernardi, Julian Pinsolle, Karim Amrane, Chantal Decroisette, Renaud Descourt, Christos Chouaid, Margaux Geier

Research

Five machine learning-based radiomics models for preoperative prediction of histological grade in hepatocellular carcinoma

Cuiyun Wu, Xingyue Du, Yang Zhang, Li Zhu, Junfa Chen, Yuan Chen, Yuguo Wei, Yang Liu

Research

Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence

Chenwei Wang, Kai Li, Zhenkun Huang, Yichuan Yuan, Wei He, Yun Zheng, Ruhai Zou, Binkui Li, Yunfei Yuan, Jiliang Qiu

Research

Genetic and epigenetic alterations in MGMT gene and correlation with concomitant chemoradiotherapy (CRT) in cervical cancer

Maneesh Kumar Gupta, Atar Singh Kushwah, Renu Singh, Kirti Srivastava, Monisha Banerjee

Research

Classification of cancer cells and gene selection based on microarray data using MOPSO algorithm

Mohammad Reza Rahimi, Dorna Makarem, Sliva Sarspy, Sobhan Akhavan Mahdavi, Mustafa Fahem Albaghdadi, Seyed Mostafa Armaghan

Research

Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses

Qingwen Zhu, Ruyue Zhang, Fei Lu, Xinyu Zhang, Daidi Zhang, Yaodong Zhang, Erfang Chen, Fugen Han, DingJun Zha

Review

Recent advances and applications of peptide–agent conjugates for targeting tumor cells

Vahab Alamdari-palangi, Khojaste Rahimi Jaberi, Mahshid Shahverdi, Yasaman Naeimzadeh, Amir Tajbakhsh, Sahar Khajeh, Vahid Razban, Jafar Fallahi

Review

Progress of immunotherapies in gestational trophoblastic neoplasms

Tong Wang, Wenxiu Guo, Xiaochen Ren, Fangfang Lang, Ying Ma, Chunping Qiu, Jie Jiang

Review

A case of endobronchial metastasis of colon cancer mimics sarcoidosis, and a review of related literature

Hui Lv, Yi Shao, Qiu-Song Chen, Wen-Jing Song, Li-Na Peng, Dian-Sheng Zhong

Review

Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials

Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Mahda Delshad, Atieh Pourbagheri-Sigaroodi, Davood Bashash

Review

Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma

Hewen Shi, Ying Zou, Weiwei Zhong, Zhaoying Li, Xiaoxue Wang, Yancun Yin, Defang Li, Ying Liu, Minjing Li

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.